87 results
8-K
EX-99.1
RPTX
Repare Therapeutics Inc
7 May 24
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
4:10pm
was primarily due to the $40.0 million Roche milestone achievement in the first quarter of 2024.
▪Research and development expenses, net of tax credits … . dollars, except share data)
As of
March 31,
As of
December 31,
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Marketable securities
Income tax receivable
8-K
EX-99.1
z09bl709t xk3vt1j0
28 Feb 24
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
7:10am
8-K
EX-99.1
wvnu09z60
9 Nov 23
Repare Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
7:05am
8-K
EX-99.1
wol01ji8
9 Aug 23
Repare Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
4:09pm
S-8
EX-99.1
yrezgobib0r5pjtg4
30 May 23
Registration of securities for employees
4:02pm
8-K
EX-99.1
ym22zyu 4pb
9 May 23
Repare Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
pr4j66tpdomr jx2wlv
9 Nov 22
Repare Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
4:05pm
424B5
54q9x k7r4fpr
4 Aug 22
Prospectus supplement for primary offering
5:00pm